Vinay Prasad recently drew outrage from conservatives, including Laura Loomer, who disagreed with his approach to approving gene therapies for rare diseases and accused him of holding liberal views.

Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash over halting Sarepta's DMD gene therapy on safety grounds. His caution drew criticism from patients,

Vinay Prasad had a problem. Several, actually. His staff at the Food and Drug Administration kept leaking to the press. He was under attack by President Trump’s allies after moving to pull a gene therapy off the market.